Where are India's Drug Patents?
As I continue to investigate global biotechnology for Scientific American and international patenting trends for DrugPatentWatch.com, I came across a curious […]
General Biotechnology
General Biotechnology
Scientific American Worldview Issue 5 at #BIO2013
I continue to measure global biotechnology innovation in the fifth edition of Scientific American Worldview. This special publication is the foundation
Scientific American Worldview Issue 5 at #BIO2013 Read Post »
General Biotechnology
Book signings at #bio2013
Join Michael Salgaller and I as we will be signing our books at the BIO bookstore on Tuesday April 23rd.
General Biotechnology
The Answers are in the Crowd? (Part 2) [live from #bio2013]
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
The Answers are in the Crowd? (Part 2) [live from #bio2013] Read Post »
General Biotechnology
Which Drug Companies Listed the Most Patents Last Year
This infographic shows the pharmaceutical companies that listed the most patents last year. The companies with the most drug patents
Which Drug Companies Listed the Most Patents Last Year Read Post »
General Biotechnology
Cancer remains the dominant disease target for biotech through to 2010
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Cancer remains the dominant disease target for biotech through to 2010
Go to paperABSTRACT: The two leading therapeutic areas for biological products, in t…
Cancer remains the dominant disease target for biotech through to 2010 Read Post »
General Biotechnology, Guest content
After Myriad Oral Argument, Supreme Court Set to Decide Patentability of Isolated Human DNA Molecules
This is a guest post by Morrison & Foerster‘s Marc A. Hearron, James J. Mullen, III and Matthew I. Kreeger. Do you have
General Biotechnology
See you at BIO in Chicago
I will be at BIO 2013, representing BiotechBlog, the Journal of Commercial Biotechnology, and Scientific American Worldview. I look forward
General Biotechnology
The SEC's enforcement programme on biotechnology's communications with the investment community
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
The SEC’s enforcement programme on biotechnology’s communications with the investment community
Go to paperABSTRACT: The proliferation of biotechnology star…
General Biotechnology, Guest content
ISO a Scientific Revolution in Cancer Research
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
